“…Myocilin is a member of the olfactomedin protein family with an N-terminal leucine zipper motif and a large C-terminal olfactomedin homology domain (Box 2). Association studies and analyses of pedigrees have shown that mutations in myocilin, especially its olfactomedin domain, are associated with a substantial fraction (>10 %) of juvenile onset glaucoma patients [2,6,7] and a smaller portion (~4%) of adult POAG cases in African-American [8], Canadian [9], Indian [10], Japanese [11], Greek [12], South African [13], Brazilian [14], Peruvian [15], Ghanaian [16], Swiss [17], and Dutch [18] populations. However, in some populations, including Moroccan [19], Middle Eastern [20], and Finnish populations [21], case-control studies failed to identify POAG-associated polymorphisms in myocilin.…”